Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024
This report looks at a study on the effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) illness and hospitalization among Alaska Native children in …
Ask aRCie
Multiple Questions About Protection From Respiratory Syncytial Virus
2024
· University of Pennsylvania
This article, written by Stanley A. Plotkin, is about protecting people from respiratory syncytial virus (RSV). It describes key questions about protecting against respiratory syncytial …
Nirsevimab: Alleviating the Burden Of RSV Morbidity in Young Children
2024
· Duke-NUS Medical School,
· KK Women's & Children's Hospital,
· University of New South Wales,
· Macquarie University,
· National Centre for Immunisation Research and Surveillance (NCIRS)
This article reviews the real-world data that supports the effectiveness of nirsevimab, a monoclonal antibody that helps protect young children from RSV. Studies have demonstrated …
Successful Implementation of Nirsevimab and Factors Influencing Uptake in Neonatal Care
This article describes how a hospital successfully used nirsevimab to prevent RSV in newborns. They offered the immunization to 99% of eligible infants, with 71% …
Nirsevimab for Respiratory Syncytial Virus Prophylaxis in Newborns and Infants
2025
· Med Uni Graz
This editorial discusses the burden of respiratory syncytial virus (RSV) infection in young children, particularly infants under 6 months old or in their first RSV …
Immunization for Respiratory Syncytial Virus-Promises and Pitfalls
This editorial discusses the potential benefits and challenges of vaccines for the respiratory syncytial virus (RSV). It explains how RSV affects children and older adults, …
Pricey or Priceless: Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention in Infants
2024
· University of Antwerp
This comment discusses the cost-effectiveness of preventing RSV in infants. It compares different strategies, like using monoclonal antibodies (nirsevimab) and a maternal vaccine (MV). It …
Introduction to This JPIDS Supplement: All Infant Protection Against Serious RSV Disease
This article describes the challenges and advancements in protecting infants from serious RSV disease. It highlights the unpredictability of RSV, especially during the COVID-19 pandemic, …
Single-Dose Nirsevimab Prevents RSV Infection
This article commentary discusses a study on nirsevimab, a single-dose treatment that helps prevent RSV infections in preterm infants. Conducted across 164 sites in 23 …
Parent Perspectives on Nirsevimab for Their Newborn
2024
· Yale School of Medicine,
· Yale University
This article explores how parents feel about using nirsevimab for their newborns. Nirsevimab is a medicine that helps protect babies from RSV, a common virus …